Device Center Seeks Panel’s Advice On Conveying Product Risks
This article was originally published in The Gray Sheet
Executive Summary
FDA says it tries to proactively communicate device risks to physicians and patients, but unique challenges in the industry sometimes hinder its efforts
You may also be interested in...
When Communicating Product Risks, FDA Should Involve Firms – AdvaMed
AdvaMed is urging FDA to "routinely" consult with manufacturers when developing and evaluating safety-related communications about devices, drugs and other regulated products
When Communicating Product Risks, FDA Should Involve Firms – AdvaMed
AdvaMed is urging FDA to "routinely" consult with manufacturers when developing and evaluating safety-related communications about devices, drugs and other regulated products
Race For FDA Commissioner Almost Over: Will It End With Sharfstein Or Califf?
The Obama transition team has concluded its search for a new FDA commissioner, stakeholders said late last week